InsiderClue
← All stocks

ImageneBio, Inc.

IMA Net buying
CIK 0001835579 #4590 in the set updated 20 Sep 2026
Bought (120 mo)
$30.40M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$815.24K
$0.00 on a plan · $26.76K straight out of an exercise
Sold at will
$788.48K
8 of 11 sales
Net
+$29.59M
+$29.61M against sales at will

By person

16 insiders · 31 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bonita David P
Director
$10.40M (7)
—
+$10.40M
419,188
$2.24M
—
Stampacchia Otello
Director
$8.00M (1)
—
+$8.00M
2,704,484
$14.44M
+1,343%
ORBIMED ADVISORS LLC entity
Director
$7.90M (6)
—
+$7.90M
418,809
$2.24M
—
Atlas Venture Fund XI, L.P. entity
10% owner
$2.00M (1)
$385.57K (3)
+$1.61M
2,116,569
$11.30M
+4.9%
FORMELA JEAN FRANCOIS
Director
$2.00M (1)
$385.57K (3)
+$1.61M
1,991,569
$10.63M
—
SLATTERY JOSEPH P
Director
$95.84K (1)
—
+$95.84K
16,000
$85.44K
—
Zhang Xiaoyan Michelle
Chief Scientific Officer
—
$26.76K (3) scheduled
−$26.76K
44,475
$237.50K
0.0%
Lally Robert B
Principal Accounting Officer
—
$17.33K (2)
−$17.33K
55,582
$296.81K
−5.4%
Wang Jonathan Jian
Director
—
—
—
1,115,005
$5.95M
—
Atlas Venture Fund X, L.P. entity
10% owner
—
—
—
749,634
$4.00M
—
Yarema Kristin
Chief Executive Officer
—
—
—
493,705
$2.64M
—
Grant-Huerta Yanina
Chief Financial Officer
—
—
—
104,000
$555.36K
—
Tessier Maude
Chief Business Officer
—
—
—
100,578
$537.09K
+249.3%
Butler Erin
Principal Accounting Officer
—
—
—
25,551
$136.44K
—
Wang Stephen Hui
Director
—
—
—
12,535
$66.94K
—
Marango Jotin
Chief Financial Officer
—
—
—
11,146
$59.52K
—

No percentages here. This company's share count has moved by a factor of 4.3 over the window, from 11,181,672 to 48,258,111 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Individual transactions

17
Insider
Date
Role
Action
Shares
Price
Amount
SLATTERY JOSEPH P
24 Dec 2025
Director
Buy
16,000
$5.99
$95.84K
Stampacchia Otello
25 Jul 2025
Director
Buy indirect
267,556
$29.90
$8.00M
Bonita David P
25 Jul 2025
Director
Buy indirect
83,611
$29.90
$2.50M
Bonita David P
24 Jun 2022
Director
Buy indirect
96,035
$5.37
$515.71K
Bonita David P
24 Jun 2022
Director
Buy indirect
65,965
$4.37
$288.27K
ORBIMED ADVISORS LLC
24 Jun 2022
Director
Buy indirect
96,035
$5.37
$515.71K
ORBIMED ADVISORS LLC
24 Jun 2022
Director
Buy indirect
65,965
$4.37
$288.27K
Bonita David P
23 Jun 2022
Director
Buy indirect
23,419
$3.71
$86.88K
ORBIMED ADVISORS LLC
23 Jun 2022
Director
Buy indirect
23,419
$3.71
$86.88K
Bonita David P
22 Jun 2022
Director
Buy indirect
66,806
$3.55
$237.16K
ORBIMED ADVISORS LLC
22 Jun 2022
Director
Buy indirect
66,806
$3.55
$237.16K
ORBIMED ADVISORS LLC
30 Mar 2021
Director
Buy indirect
48,400
$16.00
$774.40K
ORBIMED ADVISORS LLC
30 Mar 2021
Director
Buy indirect
375,000
$16.00
$6.00M
Bonita David P
30 Mar 2021
Director
Buy indirect
48,400
$16.00
$774.40K
Bonita David P
30 Mar 2021
Director
Buy indirect
375,000
$16.00
$6.00M
Atlas Venture Fund XI, L.P.
30 Mar 2021
10% owner
Buy indirect
125,000
$16.00
$2.00M
FORMELA JEAN FRANCOIS
30 Mar 2021
Director
Buy indirect
125,000
$16.00
$2.00M
Show all 31 transactions →

What was left out

Form 4 filings counted 85
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 28,423,224
Sales filed before the plan box existed 6
History held since 1 Apr 2021